Key facts
- This page summarizes Sandip I. Patel's Form 4 filing for Monterey Innovation Acquisition Corp.
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 Mar 2023, 20:44.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Other
No transaction description listed
Additional SEC filing notes
Footnote F1
The shares of common stock (the "founder shares") of Monterey Innovation Acquisition Corp. (the "Company") are held directly by NorthStar Bio Ventures, LLC (the "NorthStar Co-Sponsor"). The Reporting Person is a manager of NorthStar Co-Sponsor. Accordingly, the Reporting Person has voting and dispositive power over the founder shares held by NorthStar Co-Sponsor and may be deemed to beneficially own such shares. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Footnote F2
In connection with the Company's previously disclosed management transition, and pursuant to share transfer agreements dated March 9, 2023, NorthStar Co-Sponsor transferred (i) 478,125 founder shares to Chardan Monterey Investments LLC and (ii) 30,625 founder shares to each of the Company's three new directors, in each case, at a price of $0.006 per share.
Footnote F3
On March 9, 2023, Sanjeev Satyal resigned as the Company's Chief Executive Officer and, pursuant to an assignment dated March 9, 2023, transferred back to NorthStar Co-Sponsor 75,000 of the founder shares that he received from NorthStar Co-Sponsor prior to the Company's initial public offering.